Table 1 Clinical characteristics of the included patients and contamination of personal protective equipment according to the type of activity and contact time
From: Are coveralls required as personal protective equipment during the management of COVID-19 patients?
PPE | Patient | Type of oxygen delivery | PF ratio | Sampling days from admission | Sampling days from symptom onset | Type of activity | Aerosol generating procedures | Contact time (min) | Ct value of respiratory samples | Sites of PPE contamination (Genes, Ct value) |
|---|---|---|---|---|---|---|---|---|---|---|
1 | A | HFNC | 73 | 5 | 10 | Examination, general care | No | 20 | 22.52 | ND |
2 | B | HFNC | 125 | 3 | 11 | Examination, general care | No | 10 | 20.13 | ND |
3 | A | HFNC | 73 | 6 | 11 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample | No | 10 | 26.54 | ND |
4 | A | MV | 72 | 7 | 12 | Examination, intubation, acquisition of nasopharyngeal and lower respiratory sample, suctioning of airway | Yes (intubation, suctioning of airway) | 20 | 26.54 | ND |
5 | C | HFNC | 94 | 1 | 9 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample | No | 30 | 19.65 | ND |
6 | C | HFNC | 94 | 1 | 9 | Examination, general care | No | 30 | 19.65 | ND |
7 | C | HFNC | 69 | 2 | 10 | Examination, general care | No | 15 | 15.56 | Abdomen (RdRP/S 38.62, E 38.17, N ND) |
8 | D | NP | 243 | 2 | 2 | Examination, general care, suctioning of airway | Yes (suctioning of airway) | 15 | 13.88 | ND |
9 | C | MV | 92 | 3 | 11 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample, suctioning of airway | Yes (suctioning of airway) | 20 | 22.19 | Forearm (RdRP/S ND, E 37.91, N ND) |
10 | D | HFNC | 73 | 7 | 7 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample, suctioning of airway | Yes (suctioning of airway) | 20 | 24.23 | ND |
11 | F | HFNC | 75 | 3 | 6 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample | No | 30 | 22.63 | ND |
12 | G | HFNC | 150 | 2 | 5 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample | No | 20 | 16.87 | ND |
13 | G | HFNC | 113 | 5 | 8 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample, nebulizer | Yes (nebulizer) | 20 | 22.09 | ND |
14 | H | HFNC | 108 | 5 | 10 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample | No | 20 | 19.10 | ND |
15 | I | HFNC | 110 | 2 | 8 | Examination, general care, acquisition of nasopharyngeal and lower respiratory sample | No | 30 | 21.43 | Abdomen (RdRP/S 37.91, E ND, N ND) |